Medications

Paxlovid soon will not be free for Americans

The antiviral Paxlovid has kept patients from becoming severely ill and dying from COVID-19 since it became available—at no cost to them. But by the middle of next year, the U.S. government will stop subsidizing the medication. ...

Alzheimer's disease & dementia

Controversial Alzheimer's drug approval sparks surprising impact

When the U.S. Food and Drug Administration gave controversial accelerated approval to the first Alzheimer's drug in nearly 20 years, it had a surprising impact on attitudes about research into the disease. A survey by University ...

page 22 from 40